Press Releases and Blog
Blog
Through changes to business models and a sweeping new federal law, pharmacy benefit managers (PBMs) are already well on their way to becoming the most transparent part of the drug supply chain. A proposed Department of Labor (DOL) PBM rule, however, is raising serious concerns about competition, affordability, and regulatory overreach. Experts are warning that […]
A proposed Department of Labor (DOL) pharmacy benefit manager (PBM) disclosure rule has as a stated goal to “create a fairer and more competitive prescription drug market, lower costs, and ensure accountability across the healthcare system.” But, in practice, could that rule backfire and actually limit competition in the PBM market, heaping costly compliance burdens on smaller PBMs that drive up […]
More voices are sounding the alarm about the Department of Labor’s (DOL) harmful proposed pharmacy benefit manager (PBM) disclosure rule. The bottom line: The proposed PBM rule will increase costs for patients, employers, and taxpayers, hurt competition in the PBM market, and is duplicative of reforms already enacted by Congress. In a new American Thinker […]
Pharmacy benefit managers (PBMs) are best known for the tremendous savings they deliver to patients, employers, unions, and taxpayers. By negotiating with Big Pharma, PBMs save patients an average of $1,154 for the nearly 290 million people they serve. That equates to more than $300 billion back in the hands of families and businesses. Some […]
By Dalita Collins, Director, Policy Americans increasingly manage important aspects of their lives online—from banking and health care to employment and benefits information. The rules governing how individuals receive information about their health benefits should reflect that reality. The Department of Labor’s (DOL) proposed rule on electronic disclosure by group health plans under ERISA represents […]
For years, policymakers have called for more transparency in the prescription drug supply chain. Today, PBMs are not just meeting that challenge, they’re setting the standard. From fundamental changes to their business models to sweeping new reporting requirements enshrined in the Consolidated Appropriations Act (CAA) to a bold commitment that gives patients clearer information about […]
By Alison LaPidus, Director, Policy & Regulatory Affairs With the Medicare Part D Premium Stabilization Demonstration coming to an end this year, the Centers for Medicare & Medicaid Services (CMS) has an opportunity to build on what worked and pursue durable reforms that protect patients, strengthen competition, and help keep the program stable. At its […]
Americans are feeling the strain of rising health care costs, and prescription drugs are a growing part of the problem. That’s why the leaders of the ERISA Industry Committee (ERIC), which represents employers providing health benefits to tens of millions of workers, and the Pharmaceutical Care Management Association (PCMA), representing the companies that design and […]
Press Releases
(WASHINGTON, D.C.) — The Pharmaceutical Care Management Association (PCMA) recently released a new video ad as part of its ongoing campaign, “PBMs. Lowering Drug Costs. Protecting Patients.” The seven-figure, always-on campaign is designed to highlight the enormous and wide-ranging value pharmacy benefit managers (PBMs) provide to patients and the entire health care system. The new […]
(WASHINGTON, D.C.) — The Pharmaceutical Care Management Association (PCMA) is pleased to announce Ed DeVaney, Executive Vice President and President of CVS Caremark, CVS Health, is the new Chair of the PCMA Board of Directors. DeVaney brings more than 25 years of health care and pharmacy benefit management experience to the role, and will succeed […]
(WASHINGTON, D.C.) — The Pharmaceutical Care Management Association (PCMA) today is announcing Northwind as its newest affiliate member company. “PCMA is proud to welcome Northwind to our growing membership,” said David Marin, PCMA President and CEO. “Its focus on transparency, clinical support, and serving the unique needs of self-funded employers and union health plans underscores the […]
(WASHINGTON, D.C.) — The Pharmaceutical Care Management Association (PCMA) today applauded the House Energy and Commerce Subcommittee on Health for including H.R. 3164, the Ensuring Community Access to Pharmacist Services (ECAPS) Act in today’s hearing, Examining Legislative Proposals to Reform Medicare Provider Payment and Bolster Health Care Cybersecurity. The bipartisan ECAPS Act is a key […]
(WASHINGTON, D.C.) — Today, the Pharmaceutical Care Management Association (PCMA), released the next in its series of video ads for PCMA’s ongoing campaign, “PBMs. Lowering Drug Costs. Protecting Patients.” The seven-figure, always-on campaign is designed to highlight the significant value pharmacy benefit managers (PBMs) provide to patients and the entire health care system. The new […]
Preliminary Injunction Recognizes that Illinois Law Is Preempted by ERISA and Imposes Significant Compliance Burdens
(SPRINGFIELD, IL) – The Pharmaceutical Care Management Association (PCMA) welcomed a federal district court’s decision Monday granting a preliminary injunction against key parts of Illinois’ so-called Prescription Drug Affordability Act (PDAA). The court’s decision temporarily prevents the state from enforcing new burdensome reporting mandates on pharmacy benefit managers (PBMs) that serve self-insured employer and union-sponsored health […]
(WASHINGTON, D.C.) – In coordination with the Trump Administration and Centers for Medicare and Medicaid Services (CMS) Administrator Dr. Mehmet Oz, today the Pharmaceutical Care Management Association (PCMA) and its members announced a new commitment related to TrumpRx: “The following Pharmacy Benefit Managers, in conjunction with PCMA, the Pharmaceutical Care Management Association, commit to supporting the […]
(WASHINGTON, D.C.) – Today, the House Committee on Oversight and Government Reform is considering H.R. 6610, the Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]. The legislation mandates minimum reimbursement rates for pharmacies participating in the Federal Employee Health Benefit plan (FEHB), adding significant cost to the program with no added benefit to enrollees. David Marin, President and CEO, […]